BRAF and colorectal cancer: For example, autocrine production of the EGFR ligand TGFA was confirmed to be linked to an increased risk of developing metastasis in colorectal cancer [40], whereas a feedback activation of EGFR was responsible for the failure of BRAF inhibition in patients carrying the mutation BRAF(V600E) [41].